Company news
Latest News & Events
Company News
14 December 2021
US$1m contract with leading life sciences company for data feed from the DXRX platform
Read
Press releases
Company News
24 September 2026
Diaceutics and Syndax expand multi-year Relay partnership
Company News
14 December 2021
US$1m contract with leading life sciences company for data feed from the DXRX platform
Company News
06 April 2022
Diaceutics CEO, Peter Keeling named in The Business & Finance CEO 100 Index 2022
Company News
26 January 2023
US $7 million multi-year enterprise engagements for subscription data services
Company News
14 February 2024
Diaceutics enters into strategic alliance with KPMG
Summary of non-regulatory news and coverage for Q4, 2020
Company News
13 September 2021
DXRX platform contract win
COVID-19 Testing Data licensing agreement
Company News
Capital Markets Day 2021 Presentation
Transfer of Shares and Director PDMR Shareholding
Issue of Share Options/PDMR Shareholdings
Company News
25 March 2022
Nick Roberts joins Diaceutics as Chief Financial Officer
Notice of Capital Markets Day
Company News
Susanne Munksted named to PharmaVoice 100 list of most inspiring leaders for 2023
Diaceutics is pleased to announce that the Group's revenue for year end is ahead of revised market expectations
Company News
Diaceutics win multiple contracts for Inherited Retinal Disease (IRD) in APAC, EU, and US markets
Company News
09 December 2021
Diaceutics announces the launch of its real-time Test Signal service in the US
Stay ahead with the diaceutics newsletter
Diagnostic-driven therapies are reshaping commercialization. Get evidence-based content, expert perspectives, and practical intelligence delivered straight to your inbox, every two weeks.
Ready to do commercialization differently?
Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find themso more people get the right therapy sooner.